BILL · 2011–12 SESSION

HB 2092: Basic health plan funding

Funding the basic health plan through a tax on the windfall profits of pharmaceutical companies.

Summary

Imposes an additional tax each year for business activities conducted within this state on each person engaged in the manufacturing of drugs and requires the taxes collected to be deposited into the general fund to be used exclusively for the basic health plan.

From the Bill Digest (HB 2092), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to funding the basic health plan through a tax on the windfall profits of pharmaceutical companies;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 2092 (2025–26) Passenger rail adv. comm. · Did not pass · stalled on the House floor
HB 2092 (2023–24) School construction funding · Did not pass · died in committee
HB 2092 (2021–22) Procurement/lead times · Did not pass · died in committee
HB 2092 (2019–20) Huckleberry buyers/records · Did not pass · passed House, stalled in Senate
HB 2092 (2017–18) Immunization exemption form · Did not pass · died in committee
HB 2092 (2015–16) Nat. resources agencies/land · Did not pass · died in committee
HB 2092 (2013–14) Trans funds/public art works · Did not pass · died in committee
HB 2092 (2009–10) Dependency proceedings · Did not pass · died in committee